Document is current
Any future updates will be listed below
-
Authors
Krumwiede, Luisa https://orcid.org/0000-0001-5695-1575
Hollaus, David https://orcid.org/0000-0001-7403-6434
Valeri, Erika https://orcid.org/0009-0008-4358-1403
Schindler-Schumitsch, Karina
Bazyl, Monika A
Schiedlbauer, Johanna
Becht, Nanette N https://orcid.org/0009-0005-4672-1107
Jaritz, Markus https://orcid.org/0000-0002-9326-2047
de Almeida, Bernardo P
Schloissnig, Siegfried https://orcid.org/0000-0003-4574-8330
Burdette, Dara L https://orcid.org/0000-0003-3856-0815
Schreiber, Jacob
Stark, Alexander https://orcid.org/0000-0003-2611-0841
Gaidt, Moritz M https://orcid.org/0000-0002-8009-294X
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
EC | European Research Council (101117146)
Tempest Therapeutics
- License Information
-
More Information
Article History
Received: 12 July 2025
Revised: 13 March 2026
Accepted: 7 April 2026
First Online: 5 June 2026
Disclosure and competing interests statement
: Dara L Burdette was a stockholder and employee at Tempest Therapeutics. Moritz M Gaidt is the inventor of a patent related to this work. Work in the Gaidt laboratory was supported by Boehringer Ingelheim and Tempest Therapeutics.
